Clinical Trials Logo

Filter by:
NCT ID: NCT06424106 Not yet recruiting - PreDiabetes Clinical Trials

Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is known about the regulation of glucose concentrations in the fasting state relative to what is known about the postprandial state. The proposed experiment is part of a series of experiments designed to establish how glucagon and insulin interact with their receptors to control fasting glucose in health and in prediabetes.

NCT ID: NCT06424015 Not yet recruiting - PreDiabetes Clinical Trials

Insulin and Insulin Pulses During Fasting

Start date: September 1, 2024
Phase: N/A
Study type: Interventional

Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is known about the regulation of glucose concentrations in the fasting state relative to what is known about the postprandial state. The proposed experiment is part of a series of experiments designed to establish how glucagon and insulin interact with their receptors to control fasting glucose in health and in prediabetes.

NCT ID: NCT06423963 Recruiting - Pancreatic Cancer Clinical Trials

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

Start date: February 8, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).

NCT ID: NCT06423950 Recruiting - Pediatric Cancer Clinical Trials

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

Start date: April 30, 2024
Phase:
Study type: Observational

To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.

NCT ID: NCT06423911 Not yet recruiting - Clinical trials for Chronic Myeloid Leukemia

A Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients With CML

POLARIS-2
Start date: May 2024
Phase: Phase 3
Study type: Interventional

A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2)

NCT ID: NCT06423794 Enrolling by invitation - Bipolar Disorder Clinical Trials

BHV-7000 Open-Label Extension Bipolar Mania Study

Start date: June 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.

NCT ID: NCT06423768 Active, not recruiting - Cardiac Arrest Clinical Trials

fMRI in CardiaC arrEst With Uncertain Prognosis

FACE-UP
Start date: May 16, 2024
Phase:
Study type: Observational

The goal of this observational study is to determine whether specific advanced MRI measures are associated with functional outcomes in patients who are comatose after cardiac arrest. The main question[s] it aims to answer are: Aim 1: Determine if stimulus-based functional MRI (fMRI)-measured activations are independently associated with favorable neurological outcomes after cardiac arrest Aim 2: Determine if resting state functional MRI (rs-fMRI)-measured functional network connectivity is independently associated with favorable neurological outcomes after cardiac arrest. Aim 3: Determine if diffusion tensor imaging (DTI)-measured white matter integrity is associated with favorable neurological outcomes after cardiac arrest. Participants will undergo advanced MRI sequences at time of clinical MRI, and will be followed for 6 months post-arrest.

NCT ID: NCT06423703 Not yet recruiting - Acute Pain Clinical Trials

A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy

ALLEVIATE2
Start date: May 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a bunionectomy.

NCT ID: NCT06423664 Not yet recruiting - Developmental Delay Clinical Trials

Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure

INTACT
Start date: June 17, 2024
Phase: N/A
Study type: Interventional

The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent/infant dyads across three sites and will evaluate feasibility endpoints rather than clinical outcomes. The study duration is 22 months, including study start-up, enrollment and intervention, and data analysis and manuscript preparation.

NCT ID: NCT06423638 Recruiting - Stress Clinical Trials

Feasibility of Virtual Tai Chi Easy for Registered Nurses

TCERN
Start date: December 22, 2023
Phase: N/A
Study type: Interventional

This study will examine the feasibility of virtual Tai Chi Easy training for registered nurses and see if participation results in changes in symptoms of transition shock, healthcare-related psychological traumatic stress, burnout, somatic symptoms, and intention to quit. Participants will do virtual Tai Chi Easy for 2 hours per week and practice on their own for 40 minutes per week. The study will last six weeks. Surveys will be completed in REDCap before, during, and after the intervention.